Shilpa Medicare received GMP certification for its Jadcherla unit from AGES, Austria. The company also secured CDSCO approval to market its OERIS chemotherapy anti-nausea injection in India.
Shilpa Medicare received GMP certification for its Jadcherla unit from AGES, Austria. The company also secured CDSCO approval to market its OERIS chemotherapy anti-nausea injection in India.